by Delia Lenzi
For a long time it has been a classical science fantasy. But the idea of gene therapy – introducing copies of normal genes into people who lack them, to cure disease – it may become science fact. Last month an article published in Lancet reported great results of a phase I/II clinical trial on gene therapy for Choroideremia, an X-linked recessive disease that leads to blindness due to mutations in the CHM gene. But other groups worldwide are also moving forward.
The Economist -Science and technology section- has a easy and comprehensive article on the state of the art.